-
公开(公告)号:US08071638B2
公开(公告)日:2011-12-06
申请号:US12536682
申请日:2009-08-06
申请人: Yoav Kowalski , Ariel Mittelman , Sigalit Levi
发明人: Yoav Kowalski , Ariel Mittelman , Sigalit Levi
IPC分类号: A61K31/40 , C07D207/34
CPC分类号: C07D207/416
摘要: Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
摘要翻译: 提供阿托伐他汀钾结晶形式A,B,E,F和G。 还提供了制备阿托伐他汀钾晶型A,B,E,F和G的方法。阿托伐他汀钾结晶形式A,B,E,F和G可用于制备用于治疗高胆固醇血症或高脂血症的药物组合物 。
-
公开(公告)号:US20100041731A1
公开(公告)日:2010-02-18
申请号:US12536682
申请日:2009-08-06
申请人: Yoav KOWALSKI , Ariel Mittelman , Sigalit Levi
发明人: Yoav KOWALSKI , Ariel Mittelman , Sigalit Levi
IPC分类号: A61K31/40 , C07D207/34 , A61P9/10
CPC分类号: C07D207/416
摘要: Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
摘要翻译: 提供阿托伐他汀钾结晶形式A,B,E,F和G。 还提供了制备阿托伐他汀钾晶型A,B,E,F和G的方法。阿托伐他汀钾结晶形式A,B,E,F和G可用于制备用于治疗高胆固醇血症或高脂血症的药物组合物 。
-
公开(公告)号:US20120046335A1
公开(公告)日:2012-02-23
申请号:US13286002
申请日:2011-10-31
申请人: Yoav KOWALSKI , Ariel Mittelman , Sigalit Levi
发明人: Yoav KOWALSKI , Ariel Mittelman , Sigalit Levi
IPC分类号: A61K31/40 , A61P7/00 , C07D207/34
CPC分类号: C07D207/416
摘要: Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
摘要翻译: 提供阿托伐他汀钾结晶形式A,B,E,F和G。 还提供了制备阿托伐他汀钾晶型A,B,E,F和G的方法。阿托伐他汀钾结晶形式A,B,E,F和G可用于制备用于治疗高胆固醇血症或高脂血症的药物组合物 。
-
公开(公告)号:US20130096304A1
公开(公告)日:2013-04-18
申请号:US13535105
申请日:2012-06-27
申请人: Greta Sterimbaum , Sigalit Levi , Adi Yeori , Tamas Koltai , Valerie Niddam-Hildesheim , Maytal Piran , Shay Asis , Hagit Eisen-Nevo , David Malcolm Crowe
发明人: Greta Sterimbaum , Sigalit Levi , Adi Yeori , Tamas Koltai , Valerie Niddam-Hildesheim , Maytal Piran , Shay Asis , Hagit Eisen-Nevo , David Malcolm Crowe
IPC分类号: C07D401/14
CPC分类号: C07D401/14
摘要: Crystalline forms of Nilotinib HCl are described.
摘要翻译: 描述了盐酸尼洛替尼的结晶形式。
-
公开(公告)号:US08063250B2
公开(公告)日:2011-11-22
申请号:US12313961
申请日:2008-11-26
IPC分类号: C07C213/00
CPC分类号: C07C215/64 , C07C57/15 , C07C2601/14
摘要: Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.
摘要翻译: 提供了O-去甲基文拉法辛富马酸盐的结晶形式,其制备方法及其药物组合物。
-
公开(公告)号:US20080125476A1
公开(公告)日:2008-05-29
申请号:US11824536
申请日:2007-06-28
申请人: Santiago Ini , Sigalit Levi , Michal Rafilovich , Judith Aronhime , Mili Abramov , Ron Bar-Shavit , Eran Turgeman
发明人: Santiago Ini , Sigalit Levi , Michal Rafilovich , Judith Aronhime , Mili Abramov , Ron Bar-Shavit , Eran Turgeman
IPC分类号: A61K31/403 , C07D209/82
CPC分类号: C07D209/88
摘要: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
摘要翻译: 本发明包括磷酸卡维地洛,卡维地洛磷酸氢盐和卡维地洛二磷酸盐的新型无定形和结晶形式以及制备新型无定形和结晶形式的方法。 还公开了包含新型无定形和结晶形式及其用途的药物组合物。
-
公开(公告)号:US20070293702A1
公开(公告)日:2007-12-20
申请号:US11709906
申请日:2007-02-21
IPC分类号: C07C233/05
CPC分类号: C07C317/44
摘要: The invention encompasses crystalline forms of armodafinil, processes for preparing the crystalline forms, and pharmaceutical formulation
摘要翻译: 本发明包括结构形式的臂多巴尼,制备结晶形式的方法和药物制剂
-
公开(公告)号:US08227477B2
公开(公告)日:2012-07-24
申请号:US12612943
申请日:2009-11-05
申请人: Greta Sterimbaum , Sigalit Levi , Adi Yeori , Tamas Koltai , Valerie Niddam-Hildesheim , Maytal Piran , Shay Asis , Hagit Eisen-Nevo , David Malcolm Crowe
发明人: Greta Sterimbaum , Sigalit Levi , Adi Yeori , Tamas Koltai , Valerie Niddam-Hildesheim , Maytal Piran , Shay Asis , Hagit Eisen-Nevo , David Malcolm Crowe
IPC分类号: A01N43/54 , A61K31/505
CPC分类号: C07D401/14
摘要: Crystalline forms of Nilotinib HCl are described.
摘要翻译: 描述了盐酸尼洛替尼的结晶形式。
-
公开(公告)号:US08207361B2
公开(公告)日:2012-06-26
申请号:US13006719
申请日:2011-01-14
申请人: Evgeny Tsiperman , Sigalit Levi , Judith Aronhime , Tamas Koltai
发明人: Evgeny Tsiperman , Sigalit Levi , Judith Aronhime , Tamas Koltai
IPC分类号: C07C43/00 , C07C49/00 , C07C237/26 , A61K31/65 , A61K31/167 , A61P31/04
CPC分类号: C07C237/26
摘要: The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
摘要翻译: 本发明涉及固体结晶替加环素及其结晶形式。
-
公开(公告)号:US08124644B2
公开(公告)日:2012-02-28
申请号:US12387945
申请日:2009-05-08
申请人: Sigalit Levi
发明人: Sigalit Levi
IPC分类号: A61K31/404 , C07D209/88 , A61P9/00
CPC分类号: C07D209/88
摘要: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
摘要翻译: 本发明包括磷酸卡维地洛,卡维地洛磷酸氢盐和卡维地洛二磷酸盐的新型无定形和结晶形式以及制备新型无定形和结晶形式的方法。 还公开了包含新型无定形和结晶形式及其用途的药物组合物。
-
-
-
-
-
-
-
-
-